DE69021557D1 - Verwendung von derivaten von 9,10-dihydrophenanthren zur herstellung eines antitumoralen medikamentes und neuen derivaten daraus. - Google Patents

Verwendung von derivaten von 9,10-dihydrophenanthren zur herstellung eines antitumoralen medikamentes und neuen derivaten daraus.

Info

Publication number
DE69021557D1
DE69021557D1 DE69021557T DE69021557T DE69021557D1 DE 69021557 D1 DE69021557 D1 DE 69021557D1 DE 69021557 T DE69021557 T DE 69021557T DE 69021557 T DE69021557 T DE 69021557T DE 69021557 D1 DE69021557 D1 DE 69021557D1
Authority
DE
Germany
Prior art keywords
derivatives
dihydrophenanthrene
producing
new
antitumoral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69021557T
Other languages
English (en)
Other versions
DE69021557T2 (de
Inventor
Joerg Czech
Hans Sedlacek
Lucien Nedelec
Jacques Guillaume
Christian Marchandeau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Publication of DE69021557D1 publication Critical patent/DE69021557D1/de
Application granted granted Critical
Publication of DE69021557T2 publication Critical patent/DE69021557T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
    • C07C211/41—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems
    • C07C211/42—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems with six-membered aromatic rings being part of the condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/26—Phenanthrenes; Hydrogenated phenanthrenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69021557T 1989-12-28 1990-12-27 Verwendung von derivaten von 9,10-dihydrophenanthren zur herstellung eines antitumoralen medikamentes und neuen derivaten daraus. Expired - Fee Related DE69021557T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8917302A FR2656606B1 (fr) 1989-12-28 1989-12-28 Utilisation de derives du 9,10-dihydrophenanthrene pour la preparation d'un medicament anti-tumoral, application a titre de medicaments de derives du 9,10-dihydrophenanthrene et produits derives de cette structure.
PCT/FR1990/000952 WO1991009833A1 (fr) 1989-12-28 1990-12-27 Utilisation de derives du 9,10-dihidrophenanthrene pour la preparation d'un medicament anti-tumoral et nouveaux derives

Publications (2)

Publication Number Publication Date
DE69021557D1 true DE69021557D1 (de) 1995-09-14
DE69021557T2 DE69021557T2 (de) 1996-02-15

Family

ID=9389048

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69021557T Expired - Fee Related DE69021557T2 (de) 1989-12-28 1990-12-27 Verwendung von derivaten von 9,10-dihydrophenanthren zur herstellung eines antitumoralen medikamentes und neuen derivaten daraus.

Country Status (6)

Country Link
US (1) US5189065A (de)
EP (1) EP0461237B1 (de)
JP (1) JPH04505457A (de)
DE (1) DE69021557T2 (de)
FR (1) FR2656606B1 (de)
WO (1) WO1991009833A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2739855B1 (fr) * 1995-10-13 1997-11-14 Adir Nouvelles amines heterocycliques tertiaires, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
UA71555C2 (en) * 1997-10-06 2004-12-15 Zentaris Gmbh Methods for modulating function of serine/threonine protein kinases by 5-azaquinoline derivatives
DE10337346A1 (de) * 2003-08-12 2005-03-31 Covion Organic Semiconductors Gmbh Konjugierte Polymere enthaltend Dihydrophenanthren-Einheiten und deren Verwendung
CN111303017B (zh) * 2019-08-28 2022-11-11 上海中医药大学 一类含9,10-二氢菲骨架的化合物及其制备方法和用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4511582A (en) * 1983-06-01 1985-04-16 Burroughs Wellcome Co. Phenanthrene derivatives

Also Published As

Publication number Publication date
DE69021557T2 (de) 1996-02-15
EP0461237A1 (de) 1991-12-18
US5189065A (en) 1993-02-23
WO1991009833A1 (fr) 1991-07-11
FR2656606A1 (fr) 1991-07-05
FR2656606B1 (fr) 1993-06-25
EP0461237B1 (de) 1995-08-09
JPH04505457A (ja) 1992-09-24

Similar Documents

Publication Publication Date Title
DE3883985D1 (de) Ärztliches instrument und dessen herstellung.
DE3769812D1 (de) Verwendung von phosphordiesteraseinhibitoren und cyclischen nukleotidanalogen zur herstellung eines arzneimittels zur stimulierung der traenensekretion.
DE59006880D1 (de) Gerät zur Herstellung von Formkörpern und Verwendung desselben zur Herstellung von Inlays, Onlays, und Kronen in der Zahnmedizin.
ATE96174T1 (de) Verfahren zur herstellung von avermectine-b und die verwendeten kulturen.
DE69307733T2 (de) Calix-[4]-arene-bis-kronen, ihre herstellung und ihre anwendung zur selektiven extrahierung von cäsium und aktiniden
DE68927949T2 (de) 3,9-Diphosphaspiroundecane und Verfahren zur Herstellung von 3,9-Diphosphaspiroundecanen
ATA309588A (de) Neue kristallform von ciclosporin, verfahren zu ihrer herstellung, diese kristallform enthaltende pharmazeutische zusammensetzung und verwendung dieser kristallform
DE3785740T2 (de) Verwendung von Carboxamid-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung der Hyperlipämie.
DE68924714D1 (de) Verwendung von essentiellen fettsäuren zur herstellung eines medikaments zur behandlung von ekzemen.
DE3850154D1 (de) Verwendung von Gepiron zur Herstellung eines pharmazeutischen Präparats zur Behandlung atypischer Depression.
DE69118002T3 (de) Verfahren zur Herstellung von 1,1,1-Trifluorchlorethan und 1,1,1,2-Tetrafluorethan
FI894546A (fi) Menetelmä uusien 2'-halogeenimetylideeni-, 2'-etenylideeni- ja 2'-etynyyliadenosiinijohdannaisten valmistamiseksi
ATE136465T1 (de) Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis
DE69021557D1 (de) Verwendung von derivaten von 9,10-dihydrophenanthren zur herstellung eines antitumoralen medikamentes und neuen derivaten daraus.
DE3768150D1 (de) Verwendung eines 1,3-oxazolidin-2-on-derivates zur herstellung eines arzneimittels zur behandlung von ischaemie.
DE69205535D1 (de) Verfahren zur Herstellung von Phenylbutyronitrilen und Verwendung in der Parfümerie des 2,2-Dimethyl-4-Phenyl-Valeriannitrile.
DE68905657T2 (de) Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen.
DE69007028D1 (de) Verfahren zur Herstellung von 3,4-Epoxybutyrat und Zwischenprodukte dafür.
DE69002134D1 (de) Verfahren zur herstellung von 1,1-dichlor-1-fluoroethan und 1-chlor-1-1-difluorethan.
DE3777709D1 (de) Verwendung von 3'azido-3'deoxythymidin zur herstellung eines arzneimittels zur behandlung von gardiasis.
DE69011565T2 (de) Herstellung von Pre-Kaseinaten und Verwendung.
ATE57912T1 (de) Verfahren zur herstellung von anilinofumarat und 2,3-chinolindicarbonsaeure.
DE68920493T2 (de) Verfahren zur Herstellung von Derivaten von 2'-Deoxy-beta-cytidin und Salze davon.
DE69008488D1 (de) Verfahren zur Herstellung von N-Alkylaminophenolen und von N,N-Dialkylaminophenolen.
DE58904702D1 (de) Beta-phenoxyethylamine und deren verwendung zur herstellung von farbstoffen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee